Aspen Pharmacare Holdings Limited (APNHY): Price and Financial Metrics

Aspen Pharmacare Holdings Limited (APNHY): $12.87

0.93 (+7.77%)

POWR Rating

Component Grades

Momentum

D

Stability

A

Sentiment

Quality

F

Add APNHY to Watchlist
Sign Up

APNHY Price/Volume Stats

Current price $12.87 52-week high $13.22
Prev. close $11.95 52-week low $8.35
Day low $12.87 Volume 1,900
Day high $13.22 Avg. volume 608
50-day MA $11.17 Dividend yield 0.98%
200-day MA $9.46 Market Cap 5.74B

APNHY Stock Price Chart Interactive Chart >


Aspen Pharmacare Holdings Limited (APNHY) Company Bio


Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.


APNHY Latest News Stream


Event/Time News Detail
Loading, please wait...

APNHY Latest Social Stream


Loading social stream, please wait...

View Full APNHY Social Stream

APNHY Price Returns

1-mo N/A
3-mo N/A
6-mo 16.68%
1-year 32.16%
3-year 25.09%
5-year 85.20%
YTD 17.32%
2023 N/A
2022 N/A
2021 0.00%
2020 1.56%
2019 -11.15%

APNHY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full APNHY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!